ERBB2 and breast cancer: In this study, by means of weighted gene co-expression network analysis (WGCNA) (Langfelder & Horvath, 2008), we systematically analysed microarray-based gene expression profiling data of 310 HER2-negative BC cases treated with taxane-anthracycline neoadjuvant chemotherapy.